These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 10485483

  • 1. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA, Sitja-Arnau M, Lemoine MG, Frazier ML, Sinicrope FA.
    Cancer Res; 1999 Sep 01; 59(17):4356-62. PubMed ID: 10485483
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 3. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH.
    Anticancer Res; 2002 Oct 15; 22(4):2089-96. PubMed ID: 12174888
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
    Okami J, Yamamoto H, Fujiwara Y, Tsujie M, Kondo M, Noura S, Oshima S, Nagano H, Dono K, Umeshita K, Ishikawa O, Sakon M, Matsuura N, Nakamori S, Monden M.
    Clin Cancer Res; 1999 Aug 15; 5(8):2018-24. PubMed ID: 10473081
    [Abstract] [Full Text] [Related]

  • 5. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Ding XZ, Tong WG, Adrian TE.
    Anticancer Res; 2000 Aug 15; 20(4):2625-31. PubMed ID: 10953335
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139
    [Abstract] [Full Text] [Related]

  • 8. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI, Lao-Sirieix P, Novelli MR, Lovat LB, Sanderson IR, Fitzgerald RC.
    Clin Cancer Res; 2004 Jul 15; 10(14):4784-92. PubMed ID: 15269153
    [Abstract] [Full Text] [Related]

  • 9. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A, Memoli A, Apicella A, Tuccillo C, di Palma A, Ricchi P, Acquaviva AM, Zarrilli R.
    Oncogene; 2000 Nov 16; 19(48):5517-24. PubMed ID: 11114729
    [Abstract] [Full Text] [Related]

  • 10. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 16; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

  • 12. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S, Inoue H, Flowers LC, Sidell N.
    Clin Cancer Res; 2003 Oct 01; 9(12):4627-35. PubMed ID: 14555539
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B, Deutsch E, Eschwege P, De Crevoisier R, Nasr E, Eschwege F, Bourhis J.
    J Urol; 2003 Nov 01; 170(5):2036-9. PubMed ID: 14532848
    [Abstract] [Full Text] [Related]

  • 15. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.
    Clin Cancer Res; 2005 Sep 15; 11(18):6738-44. PubMed ID: 16166455
    [Abstract] [Full Text] [Related]

  • 16. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
    Rodríguez-Burford C, Barnes MN, Oelschlager DK, Myers RB, Talley LI, Partridge EE, Grizzle WE.
    Clin Cancer Res; 2002 Jan 15; 8(1):202-9. PubMed ID: 11801560
    [Abstract] [Full Text] [Related]

  • 17. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
    Wang HX, Chen QK.
    Ai Zheng; 2003 Jun 15; 22(6):649-52. PubMed ID: 12948419
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.